Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K De Vlam

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Rheumatology|October 14, 2009
Osteoporosis in rheumatoid arthritis and ankylosing spondylitisD Vosse, K de Vlam
Rheumatology (Oxford, England)|October 20, 2005
Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational studyK de Vlam, R J U Lories
Clinical and Experimental Rheumatology|January 1, 1996
Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction?K de Vlam, H Mielants, E M Veys
The Journal of Rheumatology|August 18, 1999
Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyteK de Vlam, H Mielants, E M Veys
The Journal of Rheumatology|December 22, 1999
Images in rheumatology: cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosisA Stuer, K de Vlam, E M Veys, et al.
The Journal of Rheumatology|July 29, 2000
The zygapophyseal joint determines morphology of the enthesophyteK de Vlam, H Mielants, K L Verstaete, et al.
Clinical and Experimental Rheumatology|September 1, 1990
The antiperinuclear factorE M Veys, F De Keyser, K De Vlam, et al.
Acta Clinica Belgica|October 9, 2009
Detection and identification of antinuclear antibodies (ANA) in a large community hospitalG Verstegen, M C Duyck, P Meeus, et al.
Clinical and Experimental Rheumatology|March 11, 2008
Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatmentR J U Lories, I Derese, F P Luyten, et al.
BMC Medical Research Methodology|June 21, 2023
Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaireP Lebughe Litite, R Westhovens, A Nkodila, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Rheumatology|October 14, 2009
Osteoporosis in rheumatoid arthritis and ankylosing spondylitisD Vosse, K de Vlam
Rheumatology (Oxford, England)|October 20, 2005
Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational studyK de Vlam, R J U Lories
Clinical and Experimental Rheumatology|January 1, 1996
Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction?K de Vlam, H Mielants, E M Veys
The Journal of Rheumatology|August 18, 1999
Involvement of the zygapophyseal joint in ankylosing spondylitis: relation to the bridging syndesmophyteK de Vlam, H Mielants, E M Veys
The Journal of Rheumatology|December 22, 1999
Images in rheumatology: cervical septic spondylodiscitis in association with diffuse idiopathic skeletal hyperostosisA Stuer, K de Vlam, E M Veys, et al.
The Journal of Rheumatology|July 29, 2000
The zygapophyseal joint determines morphology of the enthesophyteK de Vlam, H Mielants, K L Verstaete, et al.
Clinical and Experimental Rheumatology|September 1, 1990
The antiperinuclear factorE M Veys, F De Keyser, K De Vlam, et al.
Acta Clinica Belgica|October 9, 2009
Detection and identification of antinuclear antibodies (ANA) in a large community hospitalG Verstegen, M C Duyck, P Meeus, et al.
Clinical and Experimental Rheumatology|March 11, 2008
Activation of nuclear factor kappa B and mitogen activated protein kinases in psoriatic arthritis before and after etanercept treatmentR J U Lories, I Derese, F P Luyten, et al.
BMC Medical Research Methodology|June 21, 2023
Development and validation of a screening tool for SPondyloArthritis Screening in Sub-Saharan Africa: SpASSS questionnaireP Lebughe Litite, R Westhovens, A Nkodila, et al.
Pageof 5